4//SEC Filing
Rosenberg Martin 4
Accession 0001127602-12-012911
CIK 0000912183other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:11 PM ET
Size
13.1 KB
Accession
0001127602-12-012911
Insider Transaction Report
Form 4
Rosenberg Martin
Director
Transactions
- Exercise/Conversion
Common Stock
2012-04-02+10,000→ 14,658 total - Sale
Common Stock
2012-04-02$42.76/sh−10,000$427,597→ 4,658 total - Exercise/Conversion
Stock Options (Right to Buy)
2012-04-02−10,000→ 2,500 totalExercise: $21.88From: 2008-06-07Exp: 2017-06-07→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Option vests 100% on one-year anniversary of grant.
- [F2]Sold pursuant to a Rule 10(b)5-1 Plan
- [F3]This transaction was executed in multiple trades at prices ranging from $42.52 to $43.1150. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Issuer
CUBIST PHARMACEUTICALS INC
CIK 0000912183
Entity typeother
Related Parties
1- filerCIK 0001320122
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:11 PM ET
- Size
- 13.1 KB